Heyholder

This is an amended filing · View original →

‹ Activism Filings

IL DONG PHARMACEUTICAL CO., LTD. Unconfirmed response to report on sale of control of Ildong's affiliate Ildong Bio-MS, report date corrected

IL DONG PHARMACEUTICAL CO., LTD.· Clarification of Rumors or ReportsAmended

AI summary · Not investment advice

Ildong Pharmaceutical said nothing is decided on a report about selling control of its affiliate Ireed BMS, and will update by December 11.

Key facts

Clarification type
Unconfirmed
Report
Ildong Pharmaceutical pursuing sale of management control of its new drug development affiliate iLeadBMS
Company statement
The company is reviewing various possibilities from multiple angles regarding its affiliate iLeadBMS, and nothing specific has been decided so far.
Next disclosure date
Dec 11, 2026To re-disclose when confirmed or within 1 month
Media outlet
Seoul Economic Daily
Report date
Nov 12, 2026 · AmendedValue after correction

Comments

No comments yet

Comments from shareholders will appear here.